4:51 PM ET
10-Q
Financial Results
Impact Biomedical Q3 2026 Results: Net Loss of $645K, Loss Narrows
Impact BioMedical reported a net loss of $3.63 million for the nine months ended September 30, 2026, a significant improvement from the $17.11 million loss in the prior year period which was driven by a $13.21 million change in fair value of a related party note. The company maintains a minimal revenue base of $31,000 and continues to focus on developing its proprietary healthcare technologies like Linebacker™.
- Key figure
- Net loss $645K